Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway

Por Jiyi Liang, Jiyi Liang, Wei Li, Honglin Liu, Xiaofen Li, Chuqiao Yuan, Wenjun Zou, Liping Qu, Liping Qu
Publicado em 2022-04-01